摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-Methyl-3H-pyrazolo<1,2-a>benzotetrazin-3-one | 97218-56-9

中文名称
——
中文别名
——
英文名称
1-Methyl-3H-pyrazolo<1,2-a>benzotetrazin-3-one
英文别名
1-Methyl-3H-pyrazolo[1,2-a]benzo;1-methylpyrazolo[1,2-a][1,2,3,4]benzotetrazin-3-one
1-Methyl-3H-pyrazolo<1,2-a>benzotetrazin-3-one化学式
CAS
97218-56-9
化学式
C10H8N4O
mdl
——
分子量
200.2
InChiKey
ZWEYSKQUDJAYOM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    190 °C (decomp)
  • 沸点:
    334.2±25.0 °C(Predicted)
  • 密度:
    1.47±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    15
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    48.3
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    1-Methyl-3H-pyrazolo<1,2-a>benzotetrazin-3-one 在 sodium azide 作用下, 生成 2-(2-azidophenyl)-3-methyl-1H-pyrazol-5-one
    参考文献:
    名称:
    苯并四嗪衍生物中的异常取代反应
    摘要:
    1-甲基-3 H-吡唑并[1,2- a ]苯并四嗪-3-酮在醇中分解,并损失氮和分子内氢转移,形成5-烷氧基甲基-1,2-二氢-1-苯基-3 H-吡唑-3-酮。
    DOI:
    10.1039/c39850000204
  • 作为产物:
    描述:
    2-硝基苯重氮氯化物 在 palladium on activated charcoal 氢气亚硝酸 作用下, 生成 1-Methyl-3H-pyrazolo<1,2-a>benzotetrazin-3-one
    参考文献:
    名称:
    苯并四嗪衍生物中的异常取代反应
    摘要:
    1-甲基-3 H-吡唑并[1,2- a ]苯并四嗪-3-酮在醇中分解,并损失氮和分子内氢转移,形成5-烷氧基甲基-1,2-二氢-1-苯基-3 H-吡唑-3-酮。
    DOI:
    10.1039/c39850000204
点击查看最新优质反应信息

文献信息

  • ALMERICO, A. M.;BOULTON, A. J., J. CHEM. SOC. CHEM. COMMUN., 1985, N 4, 204-205
    作者:ALMERICO, A. M.、BOULTON, A. J.
    DOI:——
    日期:——
  • 1-Methyl-3<i>H</i>-pyrazolo[1,2-<i>a</i>]benzo[1,2,3,4]tetrazin-3-ones. Design, Synthesis, and Biological Activity of New Antitumor Agents
    作者:Anna Maria Almerico、Francesco Mingoia、Patrizia Diana、Paola Barraja、Antonino Lauria、Alessandra Montalbano、Girolamo Cirrincione、Gaetano Dattolo
    DOI:10.1021/jm049075u
    日期:2005.4.1
    1-Methylpyrazolo[1,2-a]benzo[1,2,3,4]tetrazin-3-ones 4, synthesized in good to excellent yields, were designed as novel alkylating agents because of their peculiar chemical behavior. All derivatives showed antiproliferative activity against more than 50 types of tumor cell lines with GI(50) reaching sub-micromolar values. SAR studies revealed that the presence of a chlorine atom is well-tolerated in both positions 8 and 9, whereas in the case of the methyl group, switching from the 8 to the 9 position gives rise to the most active compound of the series, 4g, either for the number of cell lines inhibited and for selectivity against leukaemia and renal cancer subpanels. COMPARE and 3D-MIND computations indicate, for compounds 4, an activity profile analogous to rifamycins and cytidine analogues.
  • An unusual substitution reaction in a benzotetrazine derivative
    作者:A. M. Almerico、A. J. Boulton
    DOI:10.1039/c39850000204
    日期:——
    1-Methyl-3H-pyrazolo[1,2-a]benzotetrazin-3-one decomposes in alcohols, with loss of nitrogen and intramolecular hydrogen transfer, to form 5-alkoxymethyl-1,2-dihydro-1-phenyl-3H-pyrazol-3-ones.
    1-甲基-3 H-吡唑并[1,2- a ]苯并四嗪-3-酮在醇中分解,并损失氮和分子内氢转移,形成5-烷氧基甲基-1,2-二氢-1-苯基-3 H-吡唑-3-酮。
查看更多

同类化合物

酸四嗪 甲四嗪-氨基叔丁酯 四嗪-氨基叔丁酯 嘧啶并[4,5-e]-1,2,3,4-四嗪 二甲基-1,2,4,5-四嗪 二氯均四嗪 METHYLTETRAZINE-ACID,甲基四嗪-羧基 6-苯基-1,2,4,5-四嗪-3-胺 6-乙基-1,2,4,5-四嗪-3-胺 6-丁基氨基-3-(3,5-二甲基吡唑-1-基)四嗪 6-(3,5-二甲基吡唑-1-基)-1,2,4,5-四嗪-3-胺 3,6-二苯基-1,2,4,5-四嗪 3,6-二氨基-1,2-二氢-1,2,4,5-四嗪盐酸盐 3,6-二-4-吡啶基-1,2,4,5-四嗪 3,6-二-2-吡啶基-1,2,4,5-四嗪 3,6-二(噻吩-2-基)-1,2,4,5-四嗪 3,6-二(3-吡啶基)-1,2,4,5-四氮杂苯 3,6-二(3,5-二甲基-1H-吡唑-1-基)-1,2,4,5-四嗪 1-[6-(3,5-二甲基吡唑-1-基)-1,2,4,5-四嗪-3-基]-2-(丙-2-亚基)肼 1,2-二氢-1,2,4,5-四嗪-3,6-二酮 1,2,4,5]四嗪-3,6-二羧酸 1,2,4,5-四嗪-3-胺 1,2,4,5-四嗪-3,6-二羧酸二甲酯 1,2,4,5-四嗪 (9CI)-吡咯并[2,1-d]-1,2,3,5-四嗪 (6-肼基-1,2,4,5-四嗪-3-基)肼 3-(3,5-Dimethyl-1-pyrazolyl)-6-(2-trifluoroacetylhydrazino)-1,2,4,5-tetrazine 3-cyclohexyl-6-(3,5-dimethyl-1H-pyrazol-1-yl)[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine 3-ethyl-6-(3,5-dimethyl-1H-pyrazol-1-yl)[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine 6-pentyl-6-(3,5-dimethyl-1H-pyrazol-1-yl)[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine 3-benzyl-6-(3,5-dimethyl-1H-pyrazol-1-yl)[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine 3-methyl-6-(3,5-dimethyl-1H-pyrazol-1-yl)[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine N'-(6-(3,5-dimethyl-1H-pyrazol-1-yl)-1,2,4,5-tetrazin-3-yl)propionohydrazide 3-(2-ethylidenehydrazinyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-1,2,4,5-tetrazine (1,2,4,5-tetrazine-3,6-diyl)dimethanol 3-amino-6-chloro-1,2,4,5-tetrazine 6-(3,5-dimethyl-1H-pyrazol-1-yl)-N-methyl-1,2,4,5-tetrazin-3-amine N-(tert-butyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-1,2,4,5-tetrazin-3-amine 6-(3,5-dimethyl-1H-pyrazol-1-yl)-N-(prop-2-en-1-yl)-1,2,4,5-tetrazin-3-amine 3-(2-pyrimidyl)-6-(2-hydroxy)ethyl-1,2,4,5-tetrazine 3-isopropyl-6-phenyl-1,2,4,5-tetrazine 6-butylamino-3-chlorotetrazine 3,6-di(1H-pyrazol-4-yl)-1,2,4,5-tetrazine N-(1H-tetrazol-5-yl)-1,2,4,5-tetrazin-3-amine 3-(3,5-dimethylpyrazolyl)-6-[tris(hydroxylmethyl)aminomethane]-1,2,4,5-tetrazine 2-([1,2,4]triazolo[4,3-b][1,2,4,5]tetrazin-3-ylamino)-2-(hydroxymethyl)propane-1,3-diol 6-amino-1,2,4-triazolo<4,3-b><1,2,4,5>tetrazine N-phenethyl-[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazin-3-amine 2,5-dioxopyrrolidin-1-yl 2-(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)acetate furazano-1,2,3,4-tetrazine 1,3-dioxide